Norcantharidin, Derivative of Cantharidin, for Cancer Stem Cells. (2nd September 2013)

• Record Type: Journal Article
• Authors: Hsieh, Chen-Hsi; Chao, K. S. Clifford; Liao, Hui-Fen; Chen, Yu-Jen
• Other Names: Joo Myungsoo Academic Editor.
• Is Part Of: Evidence-based complementary and alternative medicine. Volume 2013(2013)
• Publication Date: 2013-09-02
• Subjects: Alternative medicine -- Periodicals; 615.505
• DOI: 10.1155/2013/838651
• Languages: English
• ISSNs: 1741-427X

Abstract

Abstract : Cancer stem cells (CSCs) existing in human cancers have been demonstrated to be a major cause of cancer treatment resistance, invasion, metastasis, and relapse. Self-renewal pathways, Wnt/ β -catenin, Sonic hedgehog (Shh), and the Notch signaling pathway play critical roles in developing CSCs and lead to angiogenesis, migration, invasion, and metastasis. Multidrug resistance (MDR) is an unfavorable factor causing the failure of treatments against cancer cells. The most important and thoroughly studied mechanism involved in MDR is the active efflux of chemotherapeutic agents through membrane drug transporters. There is growing evidence that Norcantharidin (NCTD), a water-soluble synthetic small molecule derivative of naturally occurring cantharidin from the medicinal insect blister beetle ( Mylabris phalerata Pallas), is capable of chemoprevention and tumor inhibition. We summarize investigations into the modulation of self-renewal pathways and MDR in CSCs by NCTD. This review may aid in further investigation of using NCTD to develop more effective strategies for cancer treatment to reduce resistance and recurrence.